4//SEC Filing
O'Keefe Kenneth W 4
Accession 0001765581-24-000075
CIK 0001232524other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 6:40 PM ET
Size
7.5 KB
Accession
0001765581-24-000075
Insider Transaction Report
Form 4
O'Keefe Kenneth W
Director
Transactions
- Tax Payment
Ordinary Shares
2024-08-06$111.35/sh−1,484$165,243→ 26,970 total - Award
Ordinary Shares
2024-08-02+3,731→ 28,454 total
Holdings
- 4,445(indirect: By Trust)
Ordinary Shares
Footnotes (3)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 25, 2025.
- [F2]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F3]Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001397661
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 6:40 PM ET
- Size
- 7.5 KB